Euphorigenic and abusive properties of modafinil.
Kruszewski
Stefan P
SP
D000342:Affective Symptoms / Q000139:chemically induced; D001559:Benzhydryl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D019970:Cocaine-Related Disorders / Q000534:rehabilitation; D004348:Drug Labeling; D005059:Euphoria / Q000187:drug effects*; D006801:Humans; D000077408:Modafinil; D012107:Research Design / Q000592:standards; D019966:Substance-Related Disorders / Q000209:etiology*; D014481:United States; D014486:United States Food and Drug Administration
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil